Immunic
IMUX
53 hedge funds and large institutions have $27M invested in Immunic in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 14 increasing their positions, 19 reducing their positions, and 13 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4.31% less ownership
Funds ownership: 45.5% → 41.2% (-4.3%)
16% less funds holding
Funds holding: 63 → 53 (-10)
26% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 19
46% less call options, than puts
Call options by funds: $145K | Put options by funds: $267K
61% less capital inflows, than outflows
Capital inflows: $2.62M | Capital outflows: $6.77M
69% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$812K |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$367K |
| 3 |
Two Sigma Investments
New York
|
+$351K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$308K |
| 5 |
IAM
Innovis Asset Management
Chicago,
Illinois
|
+$166K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$1.61M |
| 2 |
Vivo Capital
Palo Alto,
California
|
-$1.59M |
| 3 |
Deep Track Capital
Greenwich,
Connecticut
|
-$774K |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
-$716K |
| 5 |
Ikarian Capital
Dallas,
Texas
|
-$384K |
IMUX Hedge Fund Activity: Q3 2023 in Review
53 of the 6,316 institutional investors tracked by Wall St. Rank reported a position in Immunic (IMUX) for Q3 2023, worth a combined $27M — down 47% from $50.7M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of IMUX and 4 opened new positions — a net loss of 9 holders — while 19 trimmed existing stakes and 14 added.
The largest buyer was Renaissance Technologies, adding an estimated $812K. The largest seller was Millennium Management, cutting an estimated $1.61M.
- 53 institutional investors held Immunic (IMUX) as of Q3 2023, down from 63 in Q2 2023.
- Funds reported $27M of Immunic stock for Q3 2023, down 47% quarter-over-quarter.
- 4 funds opened new Immunic positions in Q3 2023 and 13 closed out, a net change of -9 holders.
- The largest Immunic buyer in Q3 2023 was Renaissance Technologies, an estimated $812K added.
- The largest Immunic seller in Q3 2023 was Millennium Management, an estimated $1.61M sold.
Based on aggregated 13F filings for Q3 2023.